English
«Italy: vaccine within November» The President of IRBM: «We are ready if no hitch occurs»
photo source: Il Giornale
The University of Oxford and AstraZeneca, with the Italian involvement of IRBM, has developed the most promising coronavirus vaccine candidate. «The first 2-3 million doses of the Oxford-IRBM-AstraZeneca vaccine should arrive in Italy by the end of November, if clinical trial goes well», says Piero Di Lorenzo, President of IRBM, the Italian company located in Pomezia (Rome). «If no problem arises and the clinical trial continues as planned, the deadline already announced by the Minister of Health Speranza will be met»
Article published on Il Giornale – 17/09/2020
Download pdf
